Robert Robles
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Co-authors
- Janice C. Daniel (2 shared papers)William E. Holmes (2 shared papers)BRIAN M. FENDLY (2 shared papers)Mark Z. Jacobson (1 shared paper)Lauren Gee (1 shared paper)Guillermo Alberto Keller (1 shared paper)J W Park (1 shared paper)G K Scott (1 shared paper)
- Journals
- Molecular and Cellular Biology (2 papers)Blood (2 papers)International Journal of Epidemiology (1 paper)Journal of Clinical Oncology (1 paper)Nature Genetics (1 paper)
- Partner nations
- United StatesSpain
In The Last Decade
Robert Robles
11 papers receiving 1.4k citations
Robert Robles's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 747
- Pathology and Forensic Medicine 202
- Radiology, Nuclear Medicine and Imaging 242
- Genetics 115
- Cancer Research 126
Countries citing papers authored by Robert Robles
This map shows the geographic impact of Robert Robles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Robles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Robles more than expected).
Fields of papers citing papers by Robert Robles
This network shows the impact of papers produced by Robert Robles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Robles. The network helps show where Robert Robles may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Robles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Hit paper breakdown → | 2020 | 668 |
| 2 | 2018 | 225 | |
| 3 | 2017 | 157 | |
| 4 | 1993 | 138 | |
| 5 | 1999 | 60 | |
| 6 | 2015 | 38 | |
| 7 | 2024 | 36 | |
| 8 | 1993 | 33 | |
| 9 | 2020 | 28 | |
| 10 | 2011 | 4 | |
| 11 | 1997 | 1 | |
| 12 | 2005 | 1 |
About Robert Robles
Robert Robles is a scholar working on Genetics, Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health, having authored 12 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (1 paper) and Chromosomal and Genetic Variations (1 paper). The work is most often cited by research in Oncology (747 citations), Pathology and Forensic Medicine (202 citations), Radiology, Nuclear Medicine and Imaging (242 citations), Genetics (115 citations) and Cancer Research (126 citations). Robert Robles has collaborated with scholars based in United States and Spain. Frequent co-authors include Janice C. Daniel, William E. Holmes, BRIAN M. FENDLY, Mark Z. Jacobson, Lauren Gee, Guillermo Alberto Keller, J W Park, G K Scott, Wenlu Li and James Christopher Lee. Their work appears in journals such as Molecular and Cellular Biology, Blood, International Journal of Epidemiology, Journal of Clinical Oncology and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.